The proportion of patients achieving the ADA-recommended target of HbA1c below 7% was also substantially higher with Rybelsus: in PIONEER 7, 58% of oral semaglutide patients reached target compared with just 25% on sitagliptin meaning Rybelsus helped approximately 1.7 times more patients achieve A1C control
For example, one study showed that in people with type 2 diabetes, treatment with semaglutide (1 mg weekly) causes an average loss of about 6% of body weight over 40 weeks, while treatment with tirzepatide (15 mg/week) leads to an 11% weight loss in this population
After the new dosing schedule is agreed upon, he continues to monitor their weight and muscle mass
The question is not whether the current system will change
It begins by reducing the patients appetite for food, leading to meals that are smaller and less frequent
So, for people who have never been to Bowling Green, can you just describe it for us